Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine

ClinicalTrials.gov ID: NCT05679908

Public ClinicalTrials.gov record NCT05679908. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 9:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Randomized, Multicenter, Placebo-controlled, Three Arm Parallel Study to Evaluate the Efficacy and Safety of TNX-1900 (Intranasal Oxytocin) in Patients With Chronic Migraine (PREVENTION Study)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 2, double-blind, randomized, multicenter, placebo-controlled, three arm parallel study to evaluate the efficacy and safety of two different dosages (30 IU daily and 60 IU daily) of TNX-1900 in patients with chronic migraine.

Study identification

NCT ID
NCT05679908
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tonix Pharmaceuticals, Inc.
Industry
Enrollment
88 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 6, 2022 (Actual)
Primary completion
Oct 8, 2023 (Actual)
Completion
Oct 23, 2023 (Actual)
Last update posted
Feb 25, 2025

2022 – 2023

United States locations

U.S. sites
26
U.S. states
20
U.S. cities
26
Facility City State ZIP Site status
Preferred Research Partners, Inc. Little Rock Arkansas 72211 —
Synergy Research Centers - Synergy San Diego Lemon Grove California 91945 —
Excell Research Oceanside California 92056 —
Viking Clinical Research, LTD Temecula California 92591 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256 —
Segal Trials - Miami Lakes Medical Research Outpatient Site Miami Lakes Florida 33016 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
Diamond Headache Clinic Chicago Illinois 60642 —
Integrated Clinical Trial Services, Inc. West Des Moines Iowa 50265 —
Alliance for Multispecialty Research - Wichita West Wichita Kansas 67205 —
DelRicht Research - LCMC Health Urgent Care New Orleans Louisiana 70124 —
DelRicht Research - Neighborhood Health Prairieville Louisiana 70769 —
Boston Clinical Trials, Inc. Boston Massachusetts 02131 —
Michigan Headache & Neurological Institute Ann Arbor Michigan 48104 —
DelRicht Research - Gulfport Memorial Gulfport Mississippi 39501 —
Clinvest Research Springfield Missouri 65807 —
Alliance for Multispecialty Research - Las Vegas Las Vegas Nevada 89119 —
Upstate Clinical Research Associates, LLC Williamsville New York 14221 —
Peters Medical Research High Point North Carolina 27260 —
IPS Research Company, INC. Oklahoma City Oklahoma 73106 —
DelRicht Research - Grassroots Healthcare Tulsa Oklahoma 74133 —
Coastal Carolina Research Center North Charleston South Carolina 29405 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
Austin Clinical Trial Partners Austin Texas 78737 —
Charlottesville Medical Research, LLC Charlottesville Virginia 22911 —
Clinical Investigation Specialists, Inc. Kenosha Wisconsin 53144 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05679908, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2025 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05679908 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →